Clinical Trial

Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

Study acronym: NEURO-SCP
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes administered via intravenous and intranasal infusion.
Trial Details
NCT Number NCT07467733
Lead Sponsor Biocells Medical
Conditions Spinocerebellar Ataxia - All Sub-types
Enrollment 90 participants
Start Date 2026-06-01
Primary Completion 2028-06-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-12